Relieving treatment-resistant depression in older adults
For older adults whose depression persisted while taking an antidepressant, adding aripiprazole had greater benefits than switching to another antidepressant.
Source: nih.gov
Optimum Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Optimum Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Optimum Trial Today - Breaking & Trending Today
Antidepressant augmentation associated with improved outcomes in treatment-resistant geriatric depression
1. In older adults with treatment-resistant depression, aripiprazole-augmentation significantly improved psychological outcomes compared to bupropion-augmentation or switching to bupropion. 2. In older adults with treatment-resistant depression, bupropion-augmentation was associated with a greater risk for falls than aripiprazole-augmentation. Evidence Rating Level: 1 (Excellent) Study Rundown: Major depressive disorder (MDD) is a common condition among older adults
Source: 2minutemedicine.com